175 related articles for article (PubMed ID: 22340442)
1. Methadone and perinatal outcomes: a prospective cohort study.
Cleary BJ; Eogan M; O'Connell MP; Fahey T; Gallagher PJ; Clarke T; White MJ; McDermott C; O'Sullivan A; Carmody D; Gleeson J; Murphy DJ
Addiction; 2012 Aug; 107(8):1482-92. PubMed ID: 22340442
[TBL] [Abstract][Full Text] [Related]
2. Methadone dosing and prescribed medication use in a prospective cohort of opioid-dependent pregnant women.
Cleary BJ; Reynolds K; Eogan M; O'Connell MP; Fahey T; Gallagher PJ; Clarke T; White MJ; McDermott C; O'Sullivan A; Carmody D; Gleeson J; Murphy DJ
Addiction; 2013 Apr; 108(4):762-70. PubMed ID: 23216809
[TBL] [Abstract][Full Text] [Related]
3. Higher maternal doses of methadone does not increase neonatal abstinence syndrome.
Pizarro D; Habli M; Grier M; Bombrys A; Sibai B; Livingston J
J Subst Abuse Treat; 2011 Apr; 40(3):295-8. PubMed ID: 21255960
[TBL] [Abstract][Full Text] [Related]
4. Opioid dependency in pregnancy and length of stay for neonatal abstinence syndrome.
Pritham UA; Paul JA; Hayes MJ
J Obstet Gynecol Neonatal Nurs; 2012 Mar; 41(2):180-190. PubMed ID: 22375882
[TBL] [Abstract][Full Text] [Related]
5. Differences in the profile of neonatal abstinence syndrome signs in methadone- versus buprenorphine-exposed neonates.
Gaalema DE; Scott TL; Heil SH; Coyle MG; Kaltenbach K; Badger GJ; Arria AM; Stine SM; Martin PR; Jones HE
Addiction; 2012 Nov; 107 Suppl 1(0 1):53-62. PubMed ID: 23106927
[TBL] [Abstract][Full Text] [Related]
6. Prenatal methadone exposure, meconium biomarker concentrations and neonatal abstinence syndrome.
Gray TR; Choo RE; Concheiro M; Williams E; Elko A; Jansson LM; Jones HE; Huestis MA
Addiction; 2010 Dec; 105(12):2151-9. PubMed ID: 20854338
[TBL] [Abstract][Full Text] [Related]
7. Could prenatal food insecurity influence neonatal abstinence syndrome severity?
Rose-Jacobs R; Trevino-Talbot M; Lloyd-Travaglini C; Cabral HJ; Vibbert M; Saia K; Wachman EM
Addiction; 2019 Feb; 114(2):337-343. PubMed ID: 30422365
[TBL] [Abstract][Full Text] [Related]
8. The relationship between gestational age and the severity of neonatal abstinence syndrome.
Gibson KS; Stark S; Kumar D; Bailit JL
Addiction; 2017 Apr; 112(4):711-716. PubMed ID: 27886650
[TBL] [Abstract][Full Text] [Related]
9. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.
Kakko J; Heilig M; Sarman I
Drug Alcohol Depend; 2008 Jul; 96(1-2):69-78. PubMed ID: 18355989
[TBL] [Abstract][Full Text] [Related]
10. Antenatal methadone vs buprenorphine exposure and length of hospital stay in infants admitted to the intensive care unit with neonatal abstinence syndrome.
Tolia VN; Murthy K; Bennett MM; Miller ES; Benjamin DK; Smith PB; Clark RH
J Perinatol; 2018 Jan; 38(1):75-79. PubMed ID: 29048415
[TBL] [Abstract][Full Text] [Related]
11. Neonatal outcome following buprenorphine maintenance during conception and throughout pregnancy.
Schindler SD; Eder H; Ortner R; Rohrmeister K; Langer M; Fischer G
Addiction; 2003 Jan; 98(1):103-10. PubMed ID: 12492761
[TBL] [Abstract][Full Text] [Related]
12. Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources.
Dryden C; Young D; Hepburn M; Mactier H
BJOG; 2009 Apr; 116(5):665-71. PubMed ID: 19220239
[TBL] [Abstract][Full Text] [Related]
13. Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication.
Kaltenbach K; Holbrook AM; Coyle MG; Heil SH; Salisbury AL; Stine SM; Martin PR; Jones HE
Addiction; 2012 Nov; 107 Suppl 1(0 1):45-52. PubMed ID: 23106926
[TBL] [Abstract][Full Text] [Related]
14. Benzodiazepine withdrawal in pregnant women with opioid use disorders: An observational study of current clinical practices at a tertiary obstetrical hospital.
Gopalan P; Moses-Kolko E; Valpey R; Shenai N; Smith E
Gen Hosp Psychiatry; 2019; 57():29-33. PubMed ID: 30669023
[TBL] [Abstract][Full Text] [Related]
15. Randomized controlled trials in pregnancy: scientific and ethical aspects. Exposure to different opioid medications during pregnancy in an intra-individual comparison.
Unger A; Jagsch R; Jones H; Arria A; Leitich H; Rohrmeister K; Aschauer C; Winklbaur B; Bäwert A; Fischer G
Addiction; 2011 Jul; 106(7):1355-62. PubMed ID: 21438938
[TBL] [Abstract][Full Text] [Related]
16. Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study.
Desai RJ; Huybrechts KF; Hernandez-Diaz S; Mogun H; Patorno E; Kaltenbach K; Kerzner LS; Bateman BT
BMJ; 2015 May; 350():h2102. PubMed ID: 25975601
[TBL] [Abstract][Full Text] [Related]
17. Neonatal abstinence syndrome after methadone or buprenorphine exposure.
Jones HE; Kaltenbach K; Heil SH; Stine SM; Coyle MG; Arria AM; O'Grady KE; Selby P; Martin PR; Fischer G
N Engl J Med; 2010 Dec; 363(24):2320-31. PubMed ID: 21142534
[TBL] [Abstract][Full Text] [Related]
18. Impact of treatment approach on maternal and neonatal outcome in pregnant opioid-maintained women.
Metz V; Jagsch R; Ebner N; Würzl J; Pribasnig A; Aschauer C; Fischer G
Hum Psychopharmacol; 2011 Aug; 26(6):412-21. PubMed ID: 21823171
[TBL] [Abstract][Full Text] [Related]
19. Prospective randomised comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birthweight of newborns, early postpartum adaptation and course of the neonatal abstinence syndrome (NAS) in women followed up in the outpatient department.
Binder T; Vavrinková B
Neuro Endocrinol Lett; 2008 Feb; 29(1):80-6. PubMed ID: 18283247
[TBL] [Abstract][Full Text] [Related]
20. A Retrospective Cohort Study of Birth Outcomes in Neonates Exposed to Naltrexone in Utero: A Comparison with Methadone-, Buprenorphine- and Non-opioid-Exposed Neonates.
Kelty E; Hulse G
Drugs; 2017 Jul; 77(11):1211-1219. PubMed ID: 28536981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
